DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.

CONCLUSIONS: The overall risk of infections of DPP-4 inhibitor was not increased compared with control groups. This article is protected by copyright. All rights reserved. PMID: 26417956 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26417956?dopt=Abstract

Source: Diabetes Metab - September 29, 2015 Category: Endocrinology Authors: Yang W, Cai X, Han X, Ji L Tags: Diabetes Metab Res Rev Source Type: research